7
Participants
Start Date
July 5, 2018
Primary Completion Date
January 16, 2020
Study Completion Date
January 16, 2020
Dexamethasone
Dexamethasone will be taken orally or by IV infusion at a dose of 20 mg once-daily on days 1, 2, 8, 9, 15, 16, 22, and 23 of cycles 1-6, and at a dose 40 mg once-daily on days 1, 8, 15 of cycles 7-12.
Carfilzomib
Carfilzomib will be administered at 20 mg/m² on days 1 and 2 of the first cycle. After that, carfilzomib will be administered at 56 mg/m² on days 8, 9, 15, and 16 of the first cycle, and then on days 1, 2, 8, 9, 15, and 16 on each 28-day cycle for the cycles 2 through 6. Starting with cycle 7 through cycle 12, carfilzomib will be administered at 70 mg/m² on days 1, 8, and 15 of each 28-day cycle. All
Research Site, Bethesda
Research Site, Fredericksburg
Research Site, Winston-Salem
Research Site, Charlotte
Research Site, Charlotte
Research Site, Pinehurst
Research Site, Hendersonville
Research Site, Charleston
Research Site, Rock Hill
Research Site, Pensacola
Research Site, Orange City
Research Site, Boynton Beach
Research Site, Jackson
Research Site, Paducah
Research Site, Zanesville
Research Site, Indianapolis
Research Site, Midland
Research Site, River Forest
Research Site, Tinley Park
Research Site, Lincoln
Research Site, Fort Worth
Research Site, Houston
Research Site, Houston
Research Site, Corpus Christi
Research Site, Glenwood Springs
Research Site, Ogden
Research Site, Palm Springs
Research Site, Riverside
Research Site, Honolulu
Research Site, Yakima
Research Site, Florham Park
Lead Sponsor
Amgen
INDUSTRY